Case Review of the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery

NCT ID: NCT02085551

Last Updated: 2020-06-22

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

85 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-03-31

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary objective of this retrospective case review study is to determine the safety and effectiveness of the Penumbra and Indigo Systems for mechanical thrombectomy in a cohort of patients with confirmed peripheral or visceral arterial occlusion or embolus. This is a retrospective, single arm, multi-center trial. Up to 100 patients at up to 10 centers will be enrolled. Angiographic assessment of vessel patency at immediate post-procedure as measured by TIMI scores and procedural serious adverse events are assessed and recorded.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Arterial Occlusion or Emboli

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mechanical thrombectomy by the Indigo System

Group Type EXPERIMENTAL

Mechanical Thrombectomy by the Indigo System

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mechanical Thrombectomy by the Indigo System

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Evidence of a peripheral or visceral arterial occlusion or embolus (TIMI 0-1) prior to treatment.
* Treatment with components of the Penumbra and/or Indigo System.

Exclusion Criteria

* Participation in another clinical investigation that may confound the results of the study.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Penumbra Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richard Saxon, MD

Role: PRINCIPAL_INVESTIGATOR

Tri-City Medical Center, San Diego, CA

Corey Teigen, MD

Role: PRINCIPAL_INVESTIGATOR

Sanford Medical Center Fargo, ND

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tri-City Medical Center

San Diego, California, United States

Site Status

Baptist Health South Florida

Miami, Florida, United States

Site Status

Rush University Medical Center

Chicago, Illinois, United States

Site Status

Carolinas Medical Center

Charlotte, North Carolina, United States

Site Status

Sanford Medical Center

Fargo, North Dakota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLP 7051

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PROMISE International
NCT03321552 COMPLETED NA
The ArtixASCEND Study
NCT07135895 NOT_YET_RECRUITING NA
The Jetstream G3™ Calcium Study
NCT01273623 COMPLETED PHASE4